[1] Shepard C W, Finelli L, Alter M J. Global epidemiology of hepatitis C virus infection[J]. The Lancet infectious diseases, 2005, 5(9): 558-567. [2] Santos M A M, Souto F J D. Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study[J]. BMC Public Health, 2007, 7(1): 32. [3] Zeldis J B, Depner T A, Kuramoto I K, et al. The prevalence of hepatitis C virus antibodies among hemodialysis patients[J]. Annals of internal medicine, 1990, 112(12): 958-960. [4] Medeiros M T G, Lima J M C, Lima J W O, et al. Prevalence and associated factors to hepatitis C in hemodialysis patients in Brazil[J]. Revista de Saúde Pública, 2004, 38(2): 187-193. [5] Lemos L B, Perez R M, Lemos M M, et al. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients[J]. Nephron Clinical Practice, 2008, 108(2): c135-c140. [6] Alavian S M. A shield against a monster: Hepatitis C in hemodialysis patients[J]. World journal of gastroenterology: WJG, 2009, 15(6): 641. [7] El-Amin H H, Osman E M, Mekki M O, et al. Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report[J]. Saudi Journal of Kidney Diseases and Transplantation, 2007, 18(1): 101. [8] 颜仕鹏, 潘慧琼, 李露池, 等. 长沙地区某医院血液透析患者 HCV 感染危险因素研究[J]. 中国感染控制杂志, 2012, 11(2): 112-114.
2014, Vol. 21 
